Note: Living with IMNM is a deeply personal experience, and no two journeys look exactly alike. The information here is meant to be a resource to help you ask better questions, understand your condition, and feel more confident walking into your next appointment. It is not a substitute for personalized medical advice. Your care team knows your full history and is your best partner in making decisions about your diagnosis and treatment. When in doubt, always bring your questions to them.

 

Two hands gripping one knee.

 

Muscle weakness that makes ordinary things hard. Exhaustion that doesn’t go away, no matter how much you rest. The unsettling feeling that your body is doing something you don’t understand yet.

If you’ve been diagnosed with immune-mediated necrotizing myopathy — or if you’re still searching for answers — what you’re experiencing is real, and it has a name.

IMNM is a rare autoimmune disease where the immune system mistakenly attacks healthy muscle tissue, leading to weakness and damage over time. It’s part of a group of conditions called myositis. Learning what’s behind your symptoms is one of the most empowering things you can do — and this article is a place to start.

Living with a rare condition like immune-mediated necrotizing myopathy (IMNM) can feel overwhelming, especially when symptoms are confusing or change over time. You may notice muscle weakness, fatigue, or trouble doing everyday tasks and wonder what is happening to your body.

Understanding IMNM is an important first step. The more you know, the more confident you can feel when talking with your doctor and making decisions about your care.

What Is Immune-Mediated Necrotizing Myopathy?

Immune-mediated necrotizing myopathy (IMNM) is a rare type of myositis, which is a group of diseases that cause muscle inflammation and weakness.

In IMNM, the immune system (your body’s defense system) mistakenly attacks healthy muscle tissue. This leads to muscle damage and weakness over time.

IMNM is different from other types of myositis because:

  • Muscle damage typically happens quickly
  • Weakness is often more severe
  • Certain antibodies (proteins in the blood) are commonly involved

Common Symptoms of IMNM

Symptoms can vary from person to person, but many people with IMNM experience:

Muscle Weakness

  • Trouble climbing stairs or getting up from a chair
  • Difficulty lifting your arms (for example, brushing your hair)
  • Weakness in hips, thighs, shoulders, or upper arms

Fatigue

  • Feeling very tired, even after resting
  • Low energy that affects daily life

Muscle Pain or Tenderness

  • Aching or sore muscles
  • Sensitivity when muscles are touched

Difficulty Swallowing (Dysphagia)

  • Trouble swallowing food or liquids
  • Feeling like food is “stuck” in the throat or chest

Shortness of Breath

  • Particularly common if the lungs are affected

What Causes IMNM?

The exact cause of IMNM is not always clear, but it is considered an autoimmune disease.

In many cases, IMNM is linked to specific antibodies, including:

  • Anti-SRP antibodies
  • Anti-HMGCR antibodies

These antibodies can help doctors confirm the diagnosis. They can be detected by a blood test.

IMNM may also be associated with:

  • Certain medications, for example, statins may trigger IMNM in rare cases in people who are already predisposed, and stopping the statin alone is usually not enough to resolve symptoms.
  • Other autoimmune conditions

How Is IMNM Diagnosed?

Diagnosing IMNM, like many autoimmune diseases, can take time because its symptoms can look like other conditions. If it took a long time to get here, you’re not alone. Because IMNM shares symptoms like muscle weakness and fatigue with many other conditions — including inherited muscle disorders, thyroid problems, and medication-related muscle damage — it can take time and multiple tests before doctors find the true cause and start the right treatment.

Your doctor may use several tests, including:

Physical Exam

  • A physical exam is often one of the first steps in the diagnostic process. Your doctor will ask you to perform simple movements — like standing up from a chair, raising your arms, or pushing against gentle resistance — to assess which muscles are weak and how much your strength and function are affected. These findings help build a complete picture alongside your blood work, MRI, and biopsy results.

Blood Tests

  • A blood test called CK (creatine kinase) measures a protein that leaks into the bloodstream when muscle tissue is damaged. In people with IMNM, these levels are often very high, which can be an early clue that something is affecting the muscles.
  • Two specific antibodies — anti-SRP and anti-HMGCR — are commonly found in people with IMNM and can help confirm the diagnosis. That said, not everyone with IMNM will test positive for either one, so doctors use antibody results alongside other tests to get the full picture.

Muscle Imaging

  • Because muscle weakness alone doesn’t always tell the whole story, doctors may order an MRI scan to get a closer look at what’s happening inside the muscles. MRI can detect inflammation and damage that isn’t visible from the outside, helping your care team understand how widespread the disease is and where it’s most active.

Muscle Biopsy

  • A muscle biopsy may sound intimidating, but it’s typically a minor outpatient procedure. A small sample of muscle tissue is taken, often guided by MRI results to target the most affected area, and examined under a microscope. This allows doctors to look for the specific pattern of muscle damage that points to IMNM rather than another condition, making it one of the most important tools for confirming the diagnosis.

Treatment Options for IMNM

There is currently no cure for IMNM, but treatments can help manage symptoms and slow disease progression.

Medications

  • Corticosteroids: Corticosteroids — most commonly prednisone — are usually the first treatment prescribed for IMNM. Think of them as a way to quickly put the brakes on the immune system’s mistaken attack on your muscles. Because taking them at high doses for a long time can cause side effects like weight gain, osteoporosis, and elevated blood sugar, your doctor will likely reduce the dose over time while adding other medications to keep the disease under control.
  • Immunosuppressants: These include methotrexate or azathioprine, which are often added to help prevent the immune system from further damaging muscle tissue. They work more slowly than corticosteroids but are important for long-term disease management, allowing your doctor to gradually reduce your steroid dose over time and lower the risk of steroid-related side effects.
  • IVIG (Intravenous Immunoglobulin): IVIG is a treatment made from healthy antibodies collected from donated blood plasma. It is administered via a vein, typically at an infusion center, and each session can take several hours. IVIG helps regulate the immune system and reduce the inflammation that damages muscle tissue. It is often used in people with more severe weakness or those who do not respond fully to corticosteroids and other immunosuppressive medications.
  • Other Therapies: Some people may need additional or combination treatments to best treat their IMNM.

Physical Therapy and Daily Care

Treatment is not just about medication. Daily care plays a big role in managing IMNM, helping people maintain strength, reduce fatigue, and make everyday activities easier and safer.

 Physical Therapy

  • Helps maintain strength and mobility
  • Prevents muscle loss

Occupational Therapy

An occupational therapist can work with you to adapt daily activities to your current abilities, recommend assistive devices, and suggest modifications at home or work that help you stay as independent as possible despite muscle weakness.

Energy Management

  • Pacing activities throughout the day
  • Taking breaks to avoid overexertion

Nutrition Support

  • Eating well to support muscle health
  • Adjusting diet if swallowing is difficult

Why Early Treatment Matters

Starting treatment early can make a big difference.

Early care can:

  • Slow muscle damage
  • Improve strength over time
  • Help you maintain independence longer

If you notice new or worsening symptoms, it is important to tell your doctor right away.

Living With IMNM

Living with IMNM can be challenging, but you are not alone.

Many people find it helpful to:

  • Keep track of symptoms over time
  • Stay connected with their care team
  • Ask questions and stay informed

Like other forms of myositis, IMNM can change over time. Some days may feel harder than others but understanding your condition can help you feel more in control.

Questions to Ask Your Doctor

Bringing questions to your appointments can help you get the most out of your care. You might ask:

  • How might having IMNM affect my daily life?
  • “What do my test results mean?”
  • “How will we know if my treatment is working?”
  • “What symptoms should I watch for?”
  • “Should I adjust my activity level?”

Frequently Asked Questions

Is IMNM the same as other types of myositis?
No. While it is a form of myositis, it has some important differences. It tends to cause more severe muscle damage, can progress more quickly, and is associated with specific antibodies not seen in other types. Getting the right diagnosis matters because treatment approaches can differ.

Can IMNM go away?
IMNM doesn’t typically go away on its own, and for most people it’s a condition that requires ongoing care. But many people with IMNM respond well to treatment and are able to regain meaningful strength and function over time. Some even reach remission, a period when the disease is well controlled and symptoms are minimal. Everyone’s experience is different, and working closely with your care team gives you the best chance of finding a treatment approach that works for you.

How quickly does IMNM progress?
IMNM truly does look different from person to person. Some people notice muscle weakness coming on quickly over a matter of weeks, while others experience a much more gradual change over months or even longer. Factors such as the type of antibody you have, how early the disease was detected, and how your body responds to treatment can all play a role in how things unfold. What we do know is that early treatment matters. The sooner the immune system’s attack on muscle tissue is addressed, the better the chances of slowing damage and maintaining strength and function.

You Are Not Alone

Managing IMNM takes time, patience, and support. Learning about your condition is one of the most powerful steps you can take.

By understanding your symptoms, working closely with your care team, and staying informed, you can take an active role in your care. 

Interested in Trying PatientSpot?

Create a free account at PatientSpot.org and begin tracking your myositis symptoms today.

Are you interested in more resources about myositis?

Enter your email below to subscribe and receive our newsletter and resources!

Biliciler S, Tiniakou E. Updates in the Management of Immune-Mediated Necrotizing Myopathy Rheumatic Disease Clinics, 2025; 51, 737-759

Campanilho-Marques, R., Fonseca, J. E., & Machado, P. M. (2025). Treatment of idiopathic inflammatory myopathies. Joint Bone Spine92(6), 105932. doi: https://doi.org/10.1016/j.jbspin.2025.105932

Khan, F., Kuttikat, A. Challenges in the diagnosis and management of immune-mediated necrotizing myopathy in a patient on long-term statins, Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.042. doi: https://doi.org/10.1093/rheumatology/keac133.042

Mammen, A.L. Which nonautoimmune myopathies are most frequently misdiagnosed as myositis? Curr Opin Rheumatol. 2017 Nov;29(6):618-622. PMID: 28832350; PMCID: PMC5814131.doi: https://doi.org/10.1097/BOR.0000000000000441

Nagy S, Khan A, Machado PM, Houlden H. Inclusion body myositis: from genetics to clinical trials. J Neurol. 2023 Mar;270(3):1787-1797. doi: https://doi.org/10.1007/s00415-022-11459-3.

Pinal-Fernandez I, Casal-Dominguez M, Mammen AL. Immune-Mediated Necrotizing Myopathy. Curr Rheumatol Rep. 2018 Mar 26;20(4):21.PMID: 29582188; PMCID: PMC6019613.doi: https://doi.org/10.1007/s11926-018-0732-6

  • Was This Helpful?